Biomarkers for monitoring inhibition of IMPDH pathway

Details for Australian Patent Application No. 2005249446 (hide)

Owner Vertex Pharmaceuticals Incoporated

Inventors Ramachandran, Ravi; Botfield, Martyn; Harding, Matthew W.; Jain-Pandey, Jugnu

Agent Wrays

Pub. Number AU-A-2005249446

PCT Pub. Number WO2005/117943

Priority 60/575,076 27.05.04 US

Filing date 27 May 2005

Wipo publication date 15 December 2005

International Classifications

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

Event Publications

4 January 2007 PCT application entered the National Phase

  PCT publication WO2005/117943 Priority application(s): WO2005/117943

4 March 2010 Corrigenda

  PCT applications that have entered the National Phase - Name Index Vertex Pharmaceuticals Incoporated, Application No. 2005249446, under INID (71), correct the applicant name to Vertex Pharmaceuticals Incorporated.

23 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005249450-Cynomolgus prostate specific antigen

2005249437-Novel compounds, pharmaceutical compositions containing same, and methods of use for same